2015 Press Releases

Accuray Hosts First Regional Users’ Meeting SUNNYVALE, Calif., December 17, 2015 – Accuray Incorporated (NASDAQ: ARAY) announced today that the Accuray Exchange in Radiation Oncology (AERO™) Users’ Meeting was held November 13-14, 2015 at the University of North Carolina at Chapel Hill Friday Center for Continuing Education in Chapel Hill, North Carolina. The event attracted radiation oncologists, physicists and therapists from the United States who engaged in peer-to-peer discussions about innovation in cancer treatments, including recent developments with the CyberKnife® and TomoTherapy® Systems. Read More »
First CyberKnife® M6™ and TomoTherapy® Systems in Chile Installed at Fundacion Arturo Lopez Perez Cancer Institute SUNNYVALE, Calif., November 5, 2015 – Accuray Incorporated (NASDAQ: ARAY) announced today that the first CyberKnife® M6™ and TomoTherapy® Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems. The devices provide a noninvasive treatment option and are used worldwide for delivering precise radiation therapy while maximizing patients’ quality of life during and after treatment. The radiation therapy team at FALP expects to begin treating patients in the first quarter of 2016. Read More »
Accuray - Cowealth Arbitration Ruling Delivered SUNNYVALE, Calif., November 4, 2015 – Accuray Incorporated (NASDAQ: ARAY) announced today that the International Chamber of Commerce International Court of Arbitration (ICC) issued an interim award in an arbitration filed by Cowealth Medical Holding Co., Ltd., Accuray’s former distributor, alleging wrongful termination by Accuray of the parties’ agreement to distribute the CyberKnife® System in China. Cowealth had originally sought damages of approximately $170 million from Accuray as well as injunctive relief. The ICC verdict awarded Cowealth damages of approximately $3.4 million, while denying Cowealth’s claim for injunctive relief. Read More »
Accuray to Participate in the 24th Annual Credit Suisse Healthcare Conference SUNNYVALE, Calif., November 3, 2015-- Accuray Incorporated (Nasdaq: ARAY), announced today that a member of its management team is scheduled to present at the 24th Annual Credit Suisse Healthcare Conference in Scottsdale, Arizona on Tuesday, November 10, 2015 at 1:30pm MT / 4:30pm ET. Read More »
New CyberKnife® and TomoTherapy® System Data Presented at Leading Scientific Industry Meeting SUNNYVALE, Calif., November 2, 2015 – Accuray Incorporated (NASDAQ: ARAY) announced today that studies on the clinical use of the leading-edge CyberKnife® and TomoTherapy® Systems continue to reinforce the devices’ broad-based radiation treatment capabilities. More than 80 studies were presented during poster and oral sessions at the 57th Annual American Society for Radiation Oncology (ASTRO) Meeting in San Antonio, October 18 – 21, 2015. Some of the studies presented show long-term efficacy and safety with median follow-up exceeding five years. Read More »
Accuray Generates 10% Year-Over-Year Gross Order Growth in First Quarter SUNNYVALE, Calif., October 29, 2015 – Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the fiscal first quarter ended September 30, 2015. Read More »
Kelly Londy Named Chief Operating Officer of Accuray SUNNYVALE, Calif., October 15, 2015— Accuray Incorporated (Nasdaq: ARAY) announced today that Kelly Londy, formerly chief commercial officer has been named chief operating officer of the Company effective immediately. Ms. Londy will also remain an executive vice president of the Company. Read More »
Anova Cancer Care Treats 1,000th Prostate Cancer Patient with the CyberKnife® System SUNNYVALE, Calif., October 13, 2015 – Accuray Incorporated (NASDAQ: ARAY) announced today that Anova Cancer Care in Denver, Colorado, has treated its 1,000th prostate cancer patient with the leading-edge CyberKnife® System. Read More »

Pages